The viral co-expression of IL-7 and IL-12 in one tumor alters the immune status of non-injected tumors and significantly regresses non-injected tumors [30], suggesting a strong induction of whole-body antitumor immunity, essential for targeting metastatic diseases [69]. This evidence concerns the gene IL7 and neoplasm.